Lymphoma Trial, Recruiting NCT06781970 Sponsor: Indonesia University Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT06781970
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 60 years or older, of any gender
  • People who have immature age-related cataracts in one or both eyes, with a specific level of cloudiness and yellowing of the eye lens as measured by a standard grading system (LOC III, nuclear grades 4–6)
  • People who are willing to have cataract surgery using a standard technique called phacoemulsification, take the study medication as assigned, and attend follow-up visits over 7 weeks
  • People who have never had surgery inside the eye before
  • People who have no history of allergic reactions to vitamin C
  • People who do not regularly take vitamin supplements
  • People who agree to participate and sign the study consent form

Who may not be able to join:

  • No formal exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +62 818473841

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Indonesia University
Registry
ClinicalTrials.gov
Start date
7 December 2024
Est. completion
1 March 2025

Where this trial is recruiting

🇮🇩 Indonesia

Primary endpoints

Endothelial cell loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov